Search results
AbbVie is the new name of Allergan, a global biopharmaceutical company with over 30 brands in various therapeutic areas. Learn more about AbbVie's products, including aesthetics and eye care, and explore career opportunities.
- Products | AbbVie
View names and safety data sheets for our products.
- AbbVie Completes Transformative Acquisition of Allergan
NORTH CHICAGO, Ill., May 8, 2020 / PRNewswire / -- AbbVie...
- Products | AbbVie
Allergan Aesthetics offers a range of products and technologies for aesthetic medicine, such as BOTOX®, JUVÉDERM®, CoolSculpting®, and more. Learn about their brands, safety information, and initiatives for racial equity in aesthetic medicine.
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. [1] [2] [3] The company is the maker of Botox.
- 17,800 (2018)
- Pharmaceuticals
- $16.089 billion (2019)
People also ask
How do I contact Allergan?
Are Allergan products trademarked?
What happened to Allergan?
What does Allergan do?
Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970.
- 1948
- $6.2 billion (2013)
- 11400 (2013)
AbbVie and Allergan are now one company, bringing together over 30 brands and leadership positions in various therapeutic areas. The new AbbVie is committed to innovative science, profitable growth and global impact.
